IMV Inc. (IMV) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

IMV Inc.

IMV

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

10M

Biotechnology

0.82USD

0.00 ( 0.00%)

Market Closed (as of Apr 28, 19:58 EDT)

Relative Strenght

Volume Buzz

-71%

Earning Acce

Yes

Dist 52w H.

79%

Overview Chart

Quote Panel

Updated April 23, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
9.63M
Shares Outstanding
11.71M
Share in Float
10.17M
Dividende
0

Earning Date
No Data
Price Target
0.8225
Average Volume
152414
Beta
1.522358

Range
2.0E-4-10.4
Industry
Biotechnology
Website
https://www.imv-inc.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

-1.04x

P/B Ratio

-4.4

Debt/Equity

0.0%

Net Margin

$-4.5

EPS

How IMV compares to sector?

P/E Ratio

Fundamentals

Relative Strength

IMV

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q3.20

N/A

-1.00
vs -1.20

Q4.20

N/A

-1.10
vs -1.30

Q1.21

N/A

-1.00
vs -1.40

Q2.21

N/A

-1.10
vs -0.90

Q3.21

N/A

-1.30
vs -1.00

Q4.21

N/A

-1.40
vs -1.10

Q1.22

N/A

-1.30
vs -1.00

Q2.22

N/A

-1.20
vs -1.10

Q3.22

N/A

-1.10
vs -1.30

Q4.22

N/A

-0.99
vs -1.40

Sales Growth

YoY

Current

Estimates

Q3.20

-77%

2.2K vs 9.8K

Q4.20

-100%

111.431503 vs 25.5K

Q1.21

NA vs NA

Q2.21

NA vs NA

Q3.21

-100%

NA vs 2.2K

Q4.21

-100%

NA vs 111.431503

Q1.22

NA vs NA

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

NA vs NA

Return on Equity

QoQ

Q1.21

-27%

-0.27
vs -0.27

Q2.21

-38%

-0.38
vs -0.27

Q3.21

-32%

-0.32
vs -0.38

Q4.21

-57%

-0.57
vs -0.32

Q1.22

-93%

-0.93
vs -0.57

Q2.22

-404%

-4.04
vs -0.93

Q3.22

+118%

1.18
vs -4.04

Q4.22

+130%

1.3
vs 1.18

Institutionnal Ownership

QoQ

Q4.20

41
vs 39

Q1.21

35
vs 41

-15%

Q2.21

35
vs 35

Q3.21

32
vs 35

-9%

Q4.21

38
vs 32

19%

Q1.22

36
vs 38

-5%

Q2.22

37
vs 36

Q3.22

33
vs 37

-11%

Earnings Growth

Latest News

businesswire.com

7 hours ago

IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process

businesswire.com

12 hours ago

IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives

prnewswire.com

13 hours ago

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

prnewswire.com

14 hours ago

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

businesswire.com

16 hours ago

IMV Receives NASDAQ Delisting Notice

prnewswire.com

16 hours ago

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Company Description

0.82USD

N/A

0.00x

-1.04x

-4.4

0.0%

$-4.5

Earnings Growth

Latest News

Company Description

0.82USD

N/A

0.00x

-1.04x

-4.4

0.0%

$-4.5